Although the detrimental impact of prolonged tissue storage on nucleic acid quality is widely acknowledged, our study provides a real-world, multicentre validation specifically within the context of BRCA1/2 testing in metastatic prostate cancer on a large cohort of samples. The gene discussed is BRCA1; the disease is metastatic prostate carcinoma.